Life Science Investing Ocugen to Host Webcast on Thursday, January 15 at 8:30 a.m. ET to Discuss OCU410 Phase 2 Clinical Trial Data
Life Science Investing Ocugen Announces Publication of Phase 1 GARDian1 Trial Results for OCU410ST Modifier Gene Therapy
SAGA Metals Mobilizes for Drilling at Radar Critical Minerals Project Targeting Completion of Maiden Mineral Resource Estimate
Rio Silver Launches New Corporate Website and Expands Digital Presence as Silver Reaches Record Highs
Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis
Lahontan Drills Thick, Shallow Gold: 114m Grading 0.33 g/t Au Eq at York; 23m Grading 0.42 g/t Au Eq at Slab
